3rd Quarter - Report — PROTON THERAPY CONSORTIUM FKA NATIONAL… for PROTON THERAPY CONSORTIUM FKA NATIONAL… (2024)

Firm

PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY

Client

PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY

Income

—

Expenses

—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

address CMMI payment models like the RO Model and ROCR and prior authorization process for Medicare beneficiaries, insurance guidelines by VA and others

Lobbyist	Covered position, as disclosed
JENNIFER ROGERS MAGGIORE	Executive Director

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

Address payment models that impact reimbursement for proton therapy and prior authorization processes for Medicare beneficiaries

Lobbyist	Covered position, as disclosed
JENNIFER ROGERS MAGGIORE	Executive Director

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Prior Auth issues for proton therapy and cancer patients, bundled payment models, value of proton therapy for cancer patients and importance of access for patients,

Lobbyist	Covered position, as disclosed
JENNIFER ROGERS MAGGIORE	Executive Director

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Insurance INS

Address concerns regarding prior authorization processes for cancer patients

Lobbyist	Covered position, as disclosed
JENNIFER ROGERS MAGGIORE	Executive Director

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.